Stage 5 CKD have a glomerular filtration rate (GFR) below 15 ml/minute and therefore need renal replacement therapy (RRT), also known as dialysis. Toxic buildup (uremia) causes the development of signs and symptoms associated with CKD that can ultimately lead to end stage renal disease (ESRD) (Lancaster, 2001) .
Some of the common signs and symptoms include: increased lethargy, an inability to stay focused or concentrate on work assignments, increased swelling in the extremities, nocturia, loss of appetite, nausea, or a "sour stomach." Some individuals, especially those with diabetes, experience a metallic taste and have bad breath. High blood pressure is one of the most common manifestations associated with CKD.
PREVALENCE OF CHRONIC KIDNEY DISEASE
The prevalence of ESRD in the United States in 2000 was approximately 300,000. According to the NKF, this number is estimated to increase to 610,000 by 2010 (NKF, 2(02) . Adverse outcomes of CKD, such as cardiovascular disease, ESRD, and-premature death, have placed a critical importance on health care professionals to strategize and create treatment plans. The treatment plan goals need to focus on recommendations that delay the progression of CKD, improve patient outcomes, and ultimately decrease costs associated with RRT.
Because the number of patients with CKD is rising significantly, understanding risk factors associated with CKD is critical. Education initiatives, such as the National Pre-ESRD Education Program sponsored by Baxter Healthcare Corporation (McGaw Park, IL), focus on diet modification, medication compliance, and treatment option modalities in an attempt to keep patients healthy and off dialysis as long as possible.
RISK FACTORS
Many risk factors are associated with CKD. Studies have shown there is a higher incidence of these risk factors in some ethnic and social subgroups as reported by the United States Renal Data System (USRDS, 2002) . Early detection of CKD and development of treatment protocols to delay progression can be implemented after assessing and 
Social Factors
Social factors that place individuals at risk for developing CKD are age, ethnic minority status (e.g., African American, American Indian, Asian or Pacific Islander), exposure to certain chemicals and environmental conditions, low income, non-high school graduates, and drug abuse (Szrornba, 2(02) . The occupational health nurse should encourage at-risk employees to have routine physicals with laboratory testing to determine whether there are manifestations leading to CKD.
Diabetes
Diabetes is a disease in which the body is not able to process certain foods, in particular carbohydrates. The two types of diabetes are Type I and Type II. In Type I diabetes, the body does not produce insulin and daily injections of insulin are required. This type of diabetes occurs in young adults and children. In Type II diabetes, the pancreas produces insulin but the body is not able to use it effectively. This is caused by the inability of the glucose to travel into the cells where it is converted into metabolized energy, thereby creating an increase in the circulating blood glucose.
Ninety to ninety five percent of diabetics suffer from Type II diabetes. The cause of Type II diabetes is unknown. However, there are risk factors that predispose a person to developing this disease. Risk factors include: • Obesity. • Lack of exercise.
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• High fat and low fiber diets. • Family history. • Women who have babies weighing 4 kg at birth. • History of myocardial infarction, stroke, or hypertension. • Ethnicity (e.g., Pacific Islanders) (Szromba, 2(02) .
In the past, being older than age 40 was considered a strong risk factor. While this is still true, the risk factors are changing, and adolescent obesity is currently also a strong risk factor (National Institue of Diabetes and Digestive Kidney Diseases, 2003) .
Occupational health nurses can instruct patients with a history of diabetes to control blood glucose levels by following dietary recommendations, testing their blood glucose regularly, and taking their medication as prescribed.
Diet and exercise, while essential to maintaining control of diabetes, are also recommended treatment regimens to slow progression toward renal failure. A study conducted by the Michigan Diabetes Research and Training Center, The Diabetes Care and Complications Trail (DCCT) demonstrated that with close glucose monitoring, complications and manifestations such as retinopathy and renal failure could be thwarted or significantly delayed (University of Michigan University Record, 1993) . Therefore, employees with diabetes need to be monitored closely by their health care providers who can provide regular testing such as hemoglobin A IC to determine the level of control. Hemoglobin A IC should be tested every 6 months to show the true blood glucose levels in the body during a span of several months.
Hypertension
Hypertension has been studied for many years, and great strides have been made in creating public awareness in lifestyle modifications, such as low fat, low sodium diets, and incorporating exercise into daily routines. According to the National Heart, Lung, and Blood Institute (1997), risks associated with hypertension such as strokes, myocardial infarction, and heart failure, have decreased by approximately 40% as the result of educational initiatives such as public service announcements, early blood pressure and cholesterol screenings, and early detection by primary care physicians. Unfortunately, hypertension as a cause of ESRD has increased by 10% annualized in the past 5 years and is the leading cause of death in individuals with ESRD.
In response to this problem, the NKF established a task force to develop protocols for the management of hypertension and cardiovascular disease in this population at high risk for CKD. A goal blood pressure of 120170 mm Hg is currently recommended. There is strong correlating evidence between high blood pressure and declining GFR. Antihypertensive drug therapy, along with lipidcontrolling agents, such as atorvastatin (Lipitor) or sirnvastatin (Zocor), also are recommended (Formica, 2003) .
Associated Complication: Anemia
In addition to risk factors, CKD also has associated complications such as anemia. Anemia associated with CKD occurs when the kidney no longer releases the hormone erythropoietin (EPa). Normally, EPa sends a message to the bone marrow where red blood cell production occurs, instructing the body to produce more red blood cells. Red blood cells carry oxygen throughout the body. When CKD progresses, red blood cell production decreases, causing anemia. This decrease in red blood production also causes the heart to work harder by pumping faster to send more blood and oxygen throughout the body.
Anemia causes symptoms such as extreme fatigue. It also can cause shortness of breath from lack of circulating oxygen, or rapid or irregular heartbeat, which can lead to left ventricular hypertrophy. Left ventricular hypertrophy is an enlargement of the heart muscle that can cause complete heart failure. Additional symptoms the employee may experience are difficulty concentrating; dizziness or lightheadedness; and feeling cold and numb, especially in the extremities as a result of decreased circulating blood (Levin, 2(02) .
Education related to anemia involves instructing patients about the signs and symptoms of anemia. Nurses generally administer artificial EPa via injection when the hemoglobin falls below 10 mllmg. However, patients may be instructed about how to self administer injections in some instances. If the employee seeks assistance with these injections, the occupational health nurse needs a written order from the physician and then administration of subcutaneous injections can be taught. The prescribed dosage is determined by hemoglobin levels and weight.
Additional patient education involves explaining the need to take oral iron when prescribed because iron aids in red blood cell production. The occupational health nurse also can instruct employees to eat foods high in fiber to prevent constipation, a common side effect of taking iron. Employees also may ask the health care provider to prescribe stool softeners if constipation occurs. It is also helpful for occupational health nurses to understand several other diagnostic tests important for recognizing the progression of CKD.
DIAGNOSTIC TESTS
Diagnostic testing related to CKD involves abnormalities of the blood and urine, or abnormalities in image testing. It is not uncommon for patients with CKD to excrete albumin or total protein. This is a classic sign of glomerular disease. Sediment in the urine and abnormalities of image testing can be markers of tubulointerstitial vascular and polycystic kidney disease.
JULY 2004, VOL 52, NO.7 A typical screening test for proteinuria is a "spot" urine, which is a random untimed sample, although the first morning specimen is preferred. Dipsticks are available that can detect both protein and albumin excretion. A result of I+ or greater should be followed up with a protein-creatinine ratio, or albumin-creatinine ratio within 3 months. Two positive quantitative tests within 2 weeks requires immediate attention because this is indicative of a CKD diagnosis (KlDOQI, 2002) .
The timed urine specimen, the 24-hour collection, is no longer necessary, although it is still favored and used by many health care providers. It has been replaced by estimated formulas that are very accurate (Chahal', 1993) .
Serum creatinine level alone is not conclusive of a CKD diagnosis. However, it is needed to calculate the estimated GFR along with age, gender, and weight of the patient. This is the best diagnostic tool to determine the level of kidney function or disease stage. Many equations, all of which are found in the Kidney Disease Outcomes Quality Initiative Guideline Handbook (2002), have been developed to calculate the GFR, such as the Schwartz equation and the Counahan-Barratt equation in children and the Crockcroft-Gault equation in adults. The Crockcroft-Gault is the most commonly used equation and is: 140 minus age multiplied by weight divided by 2.2 over serum creatinine multiplied by 72 (note: the entire equation is multiplied by .85 if calculated for a woman).
Other urine tests reveal types of kidney disease. For example, blood in the urine may indicate a problem with the filtering mechanism of the kidney called glomerulonephritis or tubulointerstitial nephritis. Additional diagnostic tests to determine the cause of ESRD are biopsies and ultrasounds (NKF, 2002) .
A biopsy involves the use of a special needle inserted into the kidney. A microscopic examination can reveal the cause of CKD, such as hypertension or diabetes. The occupational health nurse should instruct employees that bleeding may occur and if they are using blood thinners, such as clopidogrel (Plavix), warfarin (Coumadin), or aspirin, they should inform their health care provider. These medications may need to be withheld for I week to 10 days prior to the procedure.
An ultrasound is a noninvasive procedure that can reveal the size of the kidneys or abnormalities of structural or functioning components of the kidney. Such findings can be: • Hydronephrosis. • Dilated calyces. • Dilated collecting ducts. • Cysts.
• Asymmetrical size of the kidneys. • Asymmetrical functioning of the kidneys.
Intravenous radiopaque dyes also can be used for diagnostic imaging. However, these dyes can cause further kidney damage and, therefore, are avoided whenever possible. After the diagnostic testing is completed and a diagnosis is derived, a treatment plan is developed based on the five stages of kidney progression established by the NKF (see Table I ) (NKF, 2002) .
DISEASE PROGRESSION
The occupational health nurse should be aware that patients with kidney infections are often placed on antibiotics and encouraged to drink plenty of water. However, as CKD progresses, these patients may be on fluid restrictions. A patient with kidney stones may need to use a strainer to catch the stones. Passing stones can be very painful, and occasionally bleeding does occur. Patients with progressed CKD may need to take extra calcium. Therefore, it is important to know the various progressive stages (see Table 1 ). When the NKF introduced the Kidney Dialysis Outcomes Quality Initiatives (KDOQI) guidelines, the intent was to improve patient outcomes and survival by providing recommendations for optimal clinical practices (Twardowski, 2(03) .
The premise behind early education programs is based on evidence that by placing patients on a modified diet of decreased protein, initiating a medication regimen of angiotensin-converting enzyme (ACE) inhibitors, and facilitating anemia management, renal disease progression can be delayed for up to 3 years. Thus, patients are healthier and kept off dialysis longer (NKF, 2002) . The occupational health nurse can playa vital role in assisting the employee with progressing CKD in understanding the importance of following the treatment regimen that may slow renal disease progression. Also, when the patient reaches Stage 5, treatment option education and timely initiation of the appropriate access are essential.
TREATMENT OPTIONS
The purpose of RRT is to remove accumulated toxins and excess fluid through the processes of diffusion (solutes moving from an area of higher concentration to an area of lower concentration) and osmosis (the movement of water across a semipermeable membrane from an area of lower solute concentration to an area of higher solute concentration). The four treatment options include:
Patients with absolute indications for hemodialysis or peritoneal dialysis as a modality represent only a small percentage of the overall population. Many individuals are clinically suitable for either therapy and should be allowed to make an educated choice based on their medical condition and lifestyle.
Hemodialysis
Hemodialysis typically takes place in a dialysis center, but also may be performed in the home environment. At the dialysis center, machines may be positioned in a large, open room, with the staff attending patients. The number of machines will vary between a few to more than 20 and sometimes even higher. The components of the hemodialysis procedure are blood access, artificial kidney or dialyzer, dialysis machine, and dialysate.
The hemodialysis access can be a fistula (i.e., a surgicallinking of an artery and vein), a graft (i.e., synthetic tubing surgically placed under the skin linking an 290 artery to a vein), or a catheter placed in the neck or shoulder. A catheter often does not allow for the needed blood flow, and frequent infections are a problem. The fistula is a preferred access as it has the best 5 year patency rate and requires fewer interventions (Besarab, 2001) . The location of a fistula and graft is usually the forearm or upper arm. Grafts also may be placed in the thigh.
Surgery for fistula placement should occur several months before dialysis is needed because maturation (the process of dilatation and thickening of the venous limb) must occur (Besarab, 2001) . Patients are given exercises to strengthen their arms during the healing time. While some advocate immediate use of a graft, delaying its use for 2 to 3 weeks allows for subcutaneous tunnel healing (Besarab, 2(01) . Fistulas and grafts are sometimes referred to as shunts.
Patients are instructed to assess their shunt daily for two things. First, they must look for the presence of a pulsating blood flow, called a "thrill." This is performed by feeling or palpating the area of the arm where the shunt was created. Second, a stethoscope must be placed over the shunt to listen for a "bruit" (loud swooshing sound). Often, the bruit can be heard even without a stethoscope. If the access is occluded or clotted, there is an absence of both bruit and thrill. If the access is warm to the touch or redness is noted, these findings are indicative of infection.
Both clotted and infected accesses require immediate intervention. During the healing process, there may be ecchymosis and swelling in the affected limb. A patient is taught to restrict the use of both the access and veins in the extremity to dialysis personnel. Laboratory draws, tourniquets, or blood pressure devices should never be used at any place on this extremity. Other protective measures should be taken, including limited weight lifting; avoiding tight jewelry and shirt cuffs on an arm access; avoiding tight socks, garters, and pants on a leg access; and using care when playing with children and pets.
Access to the dialysis machine and bloodlines is achieved by way of two needles inserted into both the arterial and venous sides of the fistula or graft. If the access is a catheter, the bloodlines are directly attached to its proximal end. The dialyzer is a manufactured semipermeable membrane allowing passage of some molecules while restricting transit of others. This membrane separates the blood compartment from the dialysate (a prepared solution that mirrors plasma concentration of essential electrolytes) (Keen, 1995) . Osmosis and diffusion occur across these fiber bundles. Only a small amount of blood is outside the body at any given time.
Pumps on the dialysis machine push the blood from the needles through the dialyzer where toxins and fluids are removed, and the cleaned blood is then returned to the patient. Settings on the machine control the amount of fluid removed, length of treatment, and blood and dialysate flow rates.
A hemodialysis treatment takes approximately 4 hours and is scheduled three times a week. Patients have their own schedules: Monday, Wednesday, and Friday or Thesday, Thursday, and Saturday. It is essential that the patient not miss the appointed time because each machine can be used for multiple "shifts" of patients a day. Many facilities have an evening shift, which allows patients to dialyze after work.
The hemodialysis schedule in the home environment is more flexible. A patient may dialyze daily for shorter periods or during the night while asleep. Typically, a partner is needed in the home environment. Advantages to incenter hemodialysis include effective removal of waste products, treatment three times a week, no equipment in the home, care given by trained professionals, and continued contact with other patients.
Disadvantages of hemodialysis include a lack of treatment schedule flexibility, more rigid restrictions of both diet and liquids, clotting of accesses, use of needles, travel to the dialysis center three times a week, and "sawtooth" therapy because of the fluid and waste products being removed more quickly than would be by a normal kidney. As a result of this rapid removal, patients may experience low blood pressure, cramps, nausea, headaches, and tiredness until they become accustomed to the treatment (Baxter Healthcare Corporation, 2(02).
Peritoneal Dialysis
Unlike hemodialysis, peritoneal dialysis takes place within the body. The components of peritoneal dialysis are the peritoneum, a peritoneal catheter as the access, and dialysate. The peritoneum is a serous membrane covering the abdominal organs (visceral peritoneum) and lining the abdominal wall (parietal peritoneum). It is a semipermeable membrane, permitting wastes from the body to cross and empty into the instilled dialysate fluid. The space between these membranes is the peritoneal cavity into which dialysate is infused. This sterile dialysate mirrors the plasma concentration of essential electrolytes along with dextrose, which creates the diffusive and osmotic gradients. A patient determines which strength of dextrose is needed based on assessment of weight, blood pressure, and the presence or absence of edema.
The access in peritoneal dialysis is a synthetic catheter, which is implanted below the waist on either side of midline. There is usually an additional extension (transfer set) attached to the end of the catheter. Access to the dialysate is through the end of this transfer set. As with hemodialysis, a patient is taught that only dialysis personnel should have access to this catheter. The exit site around the catheter is cleaned with soap and water on a daily basis and a small gauze dressing may be used. Infections of the exit site usually present with redness, drainage, crusting, and pain. Treatment of infections may include topical or systemic antibiotics. Lifting excessive amounts of weight and wearing tight clothing around the abdominal area are discouraged.
Peritoneal dialysis can be performed during the day or at night. During the day, patients perform four exchanges during which they drain the spent dialysate (effluent) from the peritoneal cavity, instill fresh solution, and then allow the solution to remain in the cavity for 4 to 6 hours (see Figure  I) . Each exchange process takes approximately 30 minutes. The amount of instilled dialysate depends on the patient's body surface area and can be 2,000 rnl or more. There is a "long dwell" while the patient is sleeping. This mode of peritoneal dialysis is continuous ambulatory peritoneal dial- ysis (CAPD). The solution to be delivered, the drain bag, and the lines are usually a one piece system. The patient also uses a cap to cover the end of the transfer set after the exchange is completed and the CAPD tubing is removed. Exchanges are performed as the patient's lifestyle allows and can be performed in a clean area where the patient has privacy. Many patients perform an exchange while at work.
Automated peritoneal dialysis (APD) is performed during the night and involves a machine (cycler). Typically, the patient connects to the cycler for approximately 9 or more hours during the night while the machine performs the exchanges. It is recommended that the patient allow dialysate to remain in the peritoneal cavity during the day to maximize the removal of waste products. This exchange is the "last fill" and is "the long dwell" of APD therapy (Burkhart, 1996) .
During the drain portion of the CAPD process and the initial drain and final drain on the cycler, the patient assesses the effluent for clarity. If there is cloudiness in the effluent, the patient follows specific procedures. Cloudiness and abdominal pain usually indicate peritonitis or infection in the peritoneal cavity. Other symptoms include nausea, vomiting, fever, and diarrhea (Leehey, 2(01) . Treatment should be immediate and usually involves administration of antibiotics in the next bag of dialysate. This solution remains in the peritoneal cavity for approximately 6 or more hours and is given on a once daily basis according to the protocols of the patient's treatment center. An alternative strategy is to add smaller amounts of antibiotics to all bags of dialysate used during each 24 hour period (Leehey, 2(01) .
Advantages to peritoneal dialysis include: • Schedule flexibility. • Ability to perform the therapy by one's self. • Ease of travel. • Liberalization of diet.
• Usually one monthly visit to the dialysis center.
• No use of needles in the exchange process. • A "steady state" therapy (continuous vs. rapid removal of waste products and excess fluids).
Disadvantages include: • Peritoneal dialysis is performed daily with no "off' days.
• Potential need for a partner to assist in performing the therapy.
• Presense of a permanent external catheter and some risk of infection. • Possible weight gain caused by the dextrose used in the dialysate (Baxter Healthcare Corporation, 2002) .
Both home hemodialysis and peritoneal dialysis require a period of home training. The amount of time needed for hemodialysis is approximately 5 or more weeks, while the home training process for peritoneal dialysis is approximately 1 to 2 weeks. This training usually takes place in the dialysis unit. Home storage space is needed for equipment and supplies.
Although hemodialysis and peritoneal dialysis are effective in removing waste products and excess fluids, they do not completely take over the work that healthy kidneys do in balancing important substances in the blood. Nutrition, exercise, and medications are important in the care of patients on dialysis. Patients may choose one option and then transfer to the other.
Transplantation
Another RRT, transplantation, is more than a surgical procedure. It is a lifelong commitment and responsibility requiring active patient participation. During a transplant, which takes between 2 and 4 hours, a healthy kidney is placed inside the patient's body. The source of the organ may be from a person who has died (cadaveric kidney) or from a living related or a living non-related donor.
The evaluation process prior to transplantation is very thorough and involves multiple appointments with physicians, social workers, clinical transplant coordinators, and psychologists. Emphasis is on the physiological age rather than the chronological age of the patient . Although transplantation is the most "natural" solution to ESRD, the NKF estimates that only approximately 50% of dialysis patients meet the physical requirements or even choose this option. It is not necessary to be on dialysis prior to the evaluation or transplant itself.
If a living donor is the source of the kidney, this person also undergoes a thorough evaluation to determine whether he or she is a suitable candidate. A healthy donor is able to live a normal life with one remaining kidney. Donation is a surgical procedure, and the length of the hospital stay may range from 5 to 7 days. A donor may return to work within a few weeks, but should avoid heavy lifting or labor until fully recoverd (l to 2 months) (Baxter Healthcare Corporation, 2002) .
If there is no living donor, the patient's name is placed on a waiting list linked to the United Network for Organ Sharing computerized database. Approximately 80% of transplanted kidneys are cadaveric kidneys. Allocation of the kidney is based on an objective point system,
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including compatibility of blood and tissue types, waiting time on list, and medical urgency . The waiting period for a kidney transplant can be as short as a few weeks or may extend to several years.
Episodes of rejection can occur because of the immune system's response to the transplanted kidney. An acute rejection occurs days to months post transplant and is manifested by fever, bloody urine, edema, pain on urination, increased blood pressure, shortness of breath, and rapid weight gain exceeding 3 pounds a day.Acute rejection often can be treated successfully by immune modification . Chronic rejection occurs slowly over months or years and is insidious in nature. Symptoms are related to the slow but permanent damage to the organ function. There is no successful treatment for chronic rejection .
The major advantages to transplantation are a usual improvement in the patient's health and the absence of dialysis. Many times, patients are able to return to their pre-ESRD lifestyles and work. While the diet is much less restrictive, nutrition continues to play a key role in their health. Monitoring by the transplant team is on a regular basis, especially during the first 3 months posttransplant. Some long term disadvantages include stomach ulcers, cataracts, steroid induced diabetes, fractures, hypertension, and recurrence of the original kidney disease in the transplanted organ . Even when patients feel well, they must continue to take immunosuppressive medications on a daily basis and on schedule. The support the occupational health nurse provides during this time of treatment choice is pivotal in assisting patients as they endeavor to balance ESRD with work issues.
No Treatment
While selecting no treatment as an option leads to death, health care providers need to respect the patient's wishes not to be treated.
ROLE OF THE OCCUPATIONAL HEALTH NURSE
By understanding the risk factors for CKD, disease progression, and treatment modalities, the occupational health nurse is in an ideal position to educate and support the employee diagnosed with CKD or ESRD. Employees in an early stage of disease progression may require educational information about diabetes, hypertension, anemia, and diet. They may need encouragement and emotional support to help promote compliance with recommendations of their health care provider or dietician. Allowing the employee to use the health office scale weekly encourages maintaining weight control. Blood pressure can be measured periodically and a card provided to the employee to show the physician on regularly scheduled visits. Blood glucose levels also may be reviewed. Regular monitoring facilitates the employee's returning to the physician sooner than scheduled if warranted.
When the disease has progressed, supporting employees becomes more challenging for the occupational health nurse. Employees may have questions about laboratory values, treatment modalities (advantages and disadvantages), symptom management, and disease progression. Employees may have concerns about lifestyle issues and may express concerns about continuing to work. Difficulties with diet and fluid restrictions are best handled by a renal dietician who can work with the physician and patient to address issues specific to the disease stage. Employees may need assistance in coordinating time off work to go to the dialysis facility for hemodialysis; locating a clean, private area to perform peritoneal dialysis while at work; or in helping social workers make travel arrangements while patients are on peritoneal dialysis or hemodialysis.
The occupational health nurse needs to understand waste disposal issues for employees who perform peritoneal dialysis at work. The occupational health nurse should recognize that quality of life challenges, psychosocial issues, and depression can occur in employees with CKD (see Figure 2 ). Quality of life for individuals with chronic illnesses encompasses changes not only in physical health and symptoms, but also in functional status, mental well-being, and social functioning (Simmons, 1990) . Individuals with kidney failure have many physical and life challenges associated not only with ESRD, but also with comorbidity issues from other disease processes. Merkus (1997) noted that "Deteriorating residual renal function may give rise to a worse perception ofquality of life by a growing awareness of complete dependence on dialysis." In addition, the negative influences of a higher number of comorbid conditions and lower hemoglobin concentrations further impact the perception of quality oflife (Merkus, 1997) . Higher hemoglobin levels have been associated with cognitive, psychological, health status, and quality of life improvements (Gregory, 2(03) . In addition, the patient's ability to maintain a sense of control and to participate in the choice of treatment modality also may playa significant factor in the perception of quality of life (Szabo, 1997) .
According to Rettig (1997) , "Patient education and selection of therapy...require time: the amount of information understood by the patient depends on the physician, the patient, their relationship, and the time available." Occupational health nurses may assist employees not only by pro- JULY 2004, VOL. 52, NO.7 moting compliance with treatment regimens (e.g., taking iron), but also by providing educational materials necessary for employees to make informed choices and by encouraging employees to discuss personal treatment modality options with their physicians or kidney health educator.
Quality of life issues for successful transplant patients surpass those of patients who have chosen other types of therapy (Simmons, 1990) . Prevalence of psychological distress occurring after ESRD has been diagnosed is approximately 25% to 35%. If individuals with a history of issues prior to diagnosis are included, approximately 40% to 50% of ESRD patients experience psychological distress no matter what treatment modality is selected (Morris, 1988) . Gregory (2003) noted, "Patients with renal disease typically have a low tolerance for exercise that can adversely affect their ability to work unaided, perform self care, do housework, pursue employment, or participate in leisure activities." Despite the challenges individuals face with their disease, patients on dialysis are often able to return to work. Studies indicate that patients with a higher level of education and those who undergo a successful transplant are more likely to return to active employment (Julius, 1989) . Because of variability in data related to the percentages of ESRD patients who are able to work, statistics are not included in this overview. When patients returning to work are undergoing peritoneal dialysis and needs to perform exchanges at work, the occupational health nurse is in an excellent position to support these employees.
Psrlloneal Dialysis al Work
Employees on CAPD may need to perform peritoneal dialysis exchanges at work. As with any personal illness, confidentiality is imperative and should be maintained. Before returning to work, best practices are to coordinate where the employee will perform dialysis exchanges and to review expectations related to hygiene and waste disposal expectations. Because the employee may need to extend lunch to perform the half hour exchange, it is best to encourage the employee to share 
Home and Work Disposal of Effluent After Peritoneal Dialysis

At Home Disposal At Work Disposal
Drain effluent from the bag and tubing as Drain effluent from the bag and tubing as much as possible and place in a plastic bag much as possible and place in red (to prevent dripping and to reduce smell).
Biohazard bag. Dispose as medical waste. Take this bag home and throwaway in Dispose of sharps in sharps container. regular trash or as recommended by local ordinances. Needles should be deposited in a 2 or 3 liter plastic bottle. capped. and thrown in the regular trash or as recommended bylocal ordinances.
the reason for the need for an extended lunch hour with a direct supervisor or human resources.
Most peritoneal dialysis systems have a two-bag system. One bag drains fluid out of the peritoneal cavity (effluent). Next, fresh solution flows in from the other bag. Employees may perform exchanges in an office, occupational health clinic setting, or a clean private area. The new dialysate is hung overhead during the exchange, which takes approximately 30 minutes. When disposing of effluent, employees should lift the toilet lid to prevent splashing on the seat. An antimicrobial spray that is bactericidal, sporicidal, virucidal (to kill both human immunodeficiency virus and hepatitis B virus), and tuberculocidal should be used by the employee to wipe off the toilet after each exchange. Drains used for peritoneal dialysis wastes should be cleaned at least weekly. As with any maintenance work, if maintenance personnel will be working on the drain or toilet used to dispose of effluent or wastes, they should follow universal precaution procedures. The occupational health nurse also should ensure that employees have a clear understanding of waste disposal expectations.
In the United States, the U.S. Environmental Protection Agency (EPA) governs the disposal of regulated waste in industry. Many states also have specific regulations for medical waste. Generally, these regulations do not include home generated waste. While there are two options for disposal, it is easier to allow employees to take care of their own waste products by taking them home and disposing of them in the regular trash (see Table 2 for at home and at work disposal methods).
Waste bags and tubing should not be placed in the regular trash at work because this could cause concern to fellow employees or janitorial staff and could lead to a coworker knowing the patient's confidential health information. In either case, disposal expectations should be discussed with employees.
Financial Considerations
In addition to health, function, and psychological stressors, employees with ESRD face challenges dealing with how to pay for hospital stays, treatments, medications, supplies, and perhaps even a transplant. Meeting financial obligations to pay the high cost associated with ESRD and transplants requires knowledge of the differ-294 ent payors as well as guidance, assistance, and support from social workers in the patient's dialysis unit. Social workers will direct the patient toward the various financial programs available and discuss the importance of the patient's visit to the Social Security office to begin the process of applying for Medicare ESRD coverage.
The role of the occupational health nurse is limited in this regard, but the nurse may be called on to provide information about the employee's health insurance coverage. Although the average transplant in 1999 cost $111,400 (Ehlers, 2002) , the patient's responsibility (primarily medications after a period of time) will be discussed by the transplant coordinator's team. The U.S. Renal Data Service estimates Medicare spends an average of $43,000 per year for ESRD treatment modalities. Hemodialysis averaged $52,000 per year. Peritoneal dialysis averaged $45,000 per year. Medicare pays an average of $57,000 per year for patients age 75 and older. When treatment modalities change, the average cost increases to $69,000 per year. (USRDS, 1999) . There is no difference in cost to a patient between hemodialysis and peritoneal dialysis.
Commercial or private insurance obtained through employment varies in its obligations to pay depending on the type of plan (e.g., indemnity, preferred provider, health maintenance organization). Some require pre-certification (approval), most require co-payments, and the policy may have limitations on what is covered. Medications may be carved out as a separate policy. Employer insurance coverage mayor may not approve transplants depending on the employer's coverage. Although part of the dialysis treatment may be covered by the employer's insurance, individuals must always investigate their qualification status under Medicare by applying for Medicare ESRD coverage.
Individuals who contributed to Medicare along with their employer during their working career and have earned enough work credits are eligible for Medicare. Medicare A hospital insurance covers acute hospital stays and assists with skilled nursing care, facility care, hospice, and home health agency care. Medicare Part B, Supplementary Medical Insurance is a voluntary program that covers physicians' fees, maintenance during dialysis treatments, certain transplants, and other services not covered under Medicare A.
Medicaid also provides medical assistance for lowincome individuals who do not meet the work criteria to (Ehlers, 2002) . The criteria may differ in each state. When the disease progression leads to employee restrictions, the occupational health nurse should assist the employer in determining what constitutes "reasonable accommodation" under the Americans With Disabilities Act. For individuals whose disease progression has made them unable to perform gainful employment, short term disability, long term disability, and Social Security disability benefits may be available.
SUMMARY
The occupational health nurse can play an important role in supporting employees with CKD and ESRD by recognizing risk factors such as diabetes and hypertension associated with CKD. The occupational health nurse should encourage compliance with treatment regimens that retard or delay progression of kidney disease into the next stage, especially blood pressure and glucose control. When employees are in need of diagnostic testing, the occupational health nurse can describe the testing procedures such as laboratory values, ultrasounds, and biopsies, and explain the five stages of CKD.
The occupational health nurse can assist employees in Stage 4 or 5 CKD in deciding on a treatment option modality that best suits their individual lifestyles, after they have seen a nephrologist and kidney patient educator. Inaddition, the occupational health nurse can guide employees with difficult lifestyle changes and provide support during the adjustment process. The occupational health nurse also can playa key role in facilitating and coordinating those changes with the renal social worker. Together they can explore available resources, such as the NKF, the American Association of Kidney Patients, and kidneydirections.com. See the Sidebar on pages 295 to 296 for other available resources.
Kidney disease can be a devastating diagnosis. Support and education are key to a successful lifestyle transition. Employees who have CKD and work with an occupational health nurse who is informed about their disease and its stages of progression can benefit from educational processes that create informed choices to delay or retard the progression of their renal disease.
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